Lynn McRoy

Overall survival results from the randomized phase 2 study of palbociclib in combination with letrozole versus letrozole alone for first-line treatment of ER+/HER2− advanced breast cancer (PALOMA-1, TRIO-18)

Richard S. Finn, Katalin Boér, Igor Bondarenko et al. · Breast Cancer Research and Treatment · 2020 · 164 citations · Full text

Comparative effectiveness of first-line palbociclib plus letrozole versus letrozole alone for HR+/HER2− metastatic breast cancer in US real-world clinical practice

Angela DeMichele, Massimo Cristofanilli, Adam Brufsky et al. · Breast Cancer Research · 2021 · 120 citations · Full text

Real-world study of overall survival with palbociclib plus aromatase inhibitor in HR+/HER2− metastatic breast cancer

Hope S. Rugo, Adam Brufsky, Xianchen Liu et al. · npj Breast Cancer · 2022 · 108 citations · Full text

Real-world evidence analysis of palbociclib prescribing patterns for patients with advanced/metastatic breast cancer treated in community oncology practice in the USA one year post approval

Jonathan Kish, Melea Ward, David Garofalo et al. · Breast Cancer Research · 2018 · 65 citations · Full text

Age Is Just a Number: Considerations for Older Adults in Cancer Clinical Trials

Dany Habr, Lynn McRoy, Vassiliki A. Papadimitrakopoulou · JNCI Journal of the National Cancer Institute · 2021 · 44 citations · Full text

Cancer Management, Cancer Registration, Geriatric Medicine +17